Migraine Global Clinical Trials Review, H2, 2017

  • ID: 4459325
  • Clinical Trials
  • Region: Global
  • 559 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Allergan Plc
  • AstraZeneca Plc
  • Banyan Group Inc
  • Eli Lilly and Co
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • MORE
Migraine Global Clinical Trials Review, H2, 2017

Summary

The clinical trial report, “Migraine Global Clinical Trials Review, H2, 2017" provides an overview of Migraine clinical trials scenario. This report provides top line data relating to the clinical trials on Migraine. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using the author’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc. across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope
  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months
Reasons to buy
  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Allergan Plc
  • AstraZeneca Plc
  • Banyan Group Inc
  • Eli Lilly and Co
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • MORE
Report Guidance
Clinical Trials Report Coverage
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Migraine to Central Nervous System Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Migraine to Central Nervous System Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Migraine Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Migraine
Nov 29, 2017: The New England Journal of Medicine Publishes Data from Pivotal Phase III Trial of Fremanezumab for the Preventive Treatment of Chronic Migraine
Nov 29, 2017: Aimovig (erenumab) Phase 3 STRIVE Data Published In The New England Journal Of Medicine Demonstrate Significant, Sustained Efficacy In Migraine Prevention
Nov 29, 2017: Allergans Migraine Leadership Recognized with Enrico Greppi Award for Excellence in Headache Research
Nov 28, 2017: Axsome Therapeutics Announces AXS-07 for the Treatment of Migraine
Nov 27, 2017: Biohaven Completes Enrollment In Second Pivotal Phase 3 Clinical Trial Of Oral CGRP-Receptor Antagonist Rimegepant
Nov 20, 2017: Biohaven Receives Agreement From FDA on Initial Pediatric Study Plan for Rimegepant, a Second Generation Oral CGRP-Receptor Antagonist for the Acute Treatment of Migraine
Nov 16, 2017: Biohaven Completes Enrollment In The First Of Two Pivotal Phase 3 Clinical Trials Of Rimegepant, A Second Generation Oral CGRP-Receptor Antagonist, For The Acute Treatment Of Migraine
Nov 15, 2017: Promius Pharma Announces ZEMBRACE SymTouch (Sumatriptan Injection) 3 mg Achieves Primary Endpoint in Post-Approval Clinical Trial
Nov 08, 2017: Zosano Pharma Announces Initiation of Long-Term Safety Study for M207 as an Acute Treatment of Migraine
Oct 31, 2017: Impel NeuroPharma Announces First Patient Dosed in Phase 1 Clinical Trial of INP104 for Treatment of Acute Migraine Headache
Oct 23, 2017: BOTOX injections may provide relief for children and teens with hard-to-treat migraines
Oct 12, 2017: Zosano Announces Publication of Pivotal Data of ADAM Zolmitriptan for the Acute Treatment of Migraine in Cephalalgia
Oct 11, 2017: Trevena Announces Update on Development Plans for Migraine Drug Candidate TRV250
Clinical Trial Profile Snapshots
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About
Contact
Source

List of Tables
Migraine Therapeutics, Global, Clinical Trials by Region, 2017*
Migraine Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017*
Migraine Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017*
Migraine Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017*
Migraine Therapeutics Clinical Trials, Europe, Top Five Countries, 2017*
Migraine Therapeutics Clinical Trials, North America, Top Countries, 2017*
Migraine Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017*
Migraine Therapeutics Clinical Trials, Central and South America, Top Countries, 2017*
Proportion of Migraine to Central Nervous System Clinical Trials, G7 Countries (%), 2017*
Migraine Therapeutics, G7 Countries, Clinical Trials by Phase, 2017*
Migraine Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017*
Proportion of Migraine to Central Nervous System Clinical Trials, E7 Countries (%), 2017*
Migraine Therapeutics, E7 Countries, Clinical Trials by Phase, 2017*
Migraine Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017*
Migraine Therapeutics, Global, Clinical Trials by Phase, 2017*
Migraine Therapeutics, Global, Clinical Trials In Progress by Phase 2017*
Migraine Therapeutics, Global, Clinical Trials by Trial Status, 2017*
Migraine Therapeutics Clinical Trials, Global, by End Point Status, 2017*
Migraine Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016
Migraine Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017*
Migraine Therapeutics Clinical Trials, Global, Key Sponsors, 2017*
Migraine Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017*
Migraine Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017*

List of Figures
Migraine Therapeutics, Global, Clinical Trials by Region (%), 2017*
Migraine Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017*
Migraine Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017*
Migraine Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017*
Migraine Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017*
Migraine Therapeutics Clinical Trials, North America, Top Countries (%), 2017*
Migraine Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017*
Migraine Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017*
Proportion of Migraine to Central Nervous System Clinical Trials, G7 Countries (%), 2017*
Migraine Therapeutics, G7 Countries, Clinical Trials by Phase, 2017*
Migraine Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017*
Proportion of Migraine to Central Nervous System Clinical Trials, E7 Countries (%), 2017*
Migraine Therapeutics, E7 Countries, Clinical Trials by Phase, 2017*
Migraine Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017*
Migraine Therapeutics, Global, Clinical Trials by Phase (%), 2017*
Migraine Therapeutics, Global, Clinical Trials In Progress by Phase, 2017*
Migraine Therapeutics, Global, Clinical Trials by Trial Status, 2017*
Migraine Therapeutics Clinical Trials, Global, by End Point Status, 2017*
Migraine Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016
Migraine Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017*
Migraine Therapeutics Clinical Trials, Global, Key Sponsors, 2017*
Migraine Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017*
Migraine Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017*
Methodology
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Merck & Co Inc
  • GlaxoSmithKline Plc
  • Allergan Plc
  • Johnson & Johnson
  • Dr. Reddy's Laboratories Ltd
  • Teva Pharmaceutical Industries Ltd
  • Pfizer Inc
  • AstraZeneca Plc
  • Eli Lilly and Co
  • Banyan Group Inc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll